![](/img/cover-not-exists.png)
PCN30 INCIDENCE OF ADVERSE EVENTS AMONG CANCER PATIENTS TREATED WITH NIVOLUMAB WITH IPILIMUMAB VERSUS NIVOLUMAB MONOTHERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS
Vyas, A., Patry, E.J., Albatal, C., Rogala, B.Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.154
Date:
May, 2019
File:
PDF, 375 KB
english, 2019